Are down-titration and discontinuation strategies of tumour necrosis factor–blocking agents for rheumatoid arthritis in patients with low disease activity possible? - A Cochrane Review summary with commentary

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
JournalInternational Journal of Rheumatic Diseases
Publication statusE-pub ahead of print - Nov 2020

ASJC Scopus subject areas

  • Rheumatology

Cite this